Home > Insider Trading > Filing (0000914190-12-000022)

Filing Details

Accession Number:: 0000914190-12-000022
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-11 16:21:07
Reporting Period:: 2012-01-09

Filing Date:: 2012-01-11
Accepted Time:: 2012-01-11 16:21:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180145	Cardiovascular Systems Inc	CSII	Surgical & Medical Instruments & Apparatus (3841)	411698056

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1067915	H John Friedman	651 Campus Drive St. Paul MN 55112		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-09	13,500	$10.41	295,133	No	4	S	Indirect	Easton Hunt Capital Partners, L.P.
Common Stock	Disposition	2012-01-10	13,500	$10.43	281,633	No	4	S	Indirect	Easton Hunt Capital Partners, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Easton Hunt Capital Partners, L.P.
No	4	S	Indirect	Easton Hunt Capital Partners, L.P.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,000	Direct
Common Stock	421,023	Indirect	Easton Capital Partners, LP

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$7.90		2017-10-08	4,321	4,321	Direct
Common Stock	Stock Option (right to buy)	$11.38		2017-11-12	15,088	15,088	Direct
Common Stock	Stock Option (right to buy)	$8.83		2016-08-14	38,820	38,820	Direct
Common Stock	Restricted Stock Units	$0.00			5,714	5,714	Direct
Common Stock	Restricted Stock Units	$0.00			11,628	11,628	Direct
Common Stock	Restricted Stock Units	$0.00			21,739	21,739	Direct
Common Stock	Restricted Stock Units	$0.00			7,192	7,192	Direct
Common Stock	Warrant (Right to Buy)	$9.28	2008-09-12	2013-09-12	107,833	107,833	Indirect
Common Stock	Warrant (Right to Buy)	$8.83	2009-02-25	2014-02-24	151,617	151,617	Indirect
Common Stock	Warrant (Right to Buy)	$8.83	2009-02-25	2014-02-24	151,617	151,617	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-10-08	4,321	4,321	Direct
2017-11-12	15,088	15,088	Direct
2016-08-14	38,820	38,820	Direct
	5,714	5,714	Direct
	11,628	11,628	Direct
	21,739	21,739	Direct
	7,192	7,192	Direct
2013-09-12	107,833	107,833	Indirect
2014-02-24	151,617	151,617	Indirect
2014-02-24	151,617	151,617	Indirect

Footnotes

The sale of the underlying shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Easton Hunt Capital Partners, L.P. on November 30, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.35 to $10.47 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.36 to $10.46 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Mr. Friedman disclaims beneficial ownership of shares held by Easton Hunt Capital Partners, L.P. and Easton Capital Partners, LP except to the extent of his pecuniary interest therein.
Fully exercisable.
Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in shares of the Company's Common Stock beginning six months following the termination of each director's board membership.
Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash or shares of the Company's Common Stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in remaining quarterly amounts of 1,798 on each of 3/31/2012 and 6/30/2012.
Mr. Friedman disclaims beneficial ownership of warrants held by Easton Hunt Capital Partners, L.P. and Easton Capital Partners, LP except to the extent of his pecuniary interest therein.